Construction of Induced Pluripotent Stem Cell Line (Zzui031-A) of a Healthy Young Chinese Han Male

Shaohua Li,Yunchao Wang,Huifang Sun,Zhuoya Wang,Qi Zhang,Yanlin Wang,Jing Yang,Changhe Shi,Yanpeng Yuan,Hao Wang,Liyuan Fan,Zhuo Li,Yuming Xu

DOI: https://doi.org/10.1016/j.scr.2021.102608

IF: 1.587

2021-01-01

Stem Cell Research

Abstract:We have successively constructed several induced pluripotent stem cell (iPSC) lines of middle-aged and elderly male, but cell samples from young donors are still scarce. In this project, we recruited a healthy 29-year-old Chinese Han male, obtained his skin fibroblasts and successfully established iPSC line using non-integrated reprogramming technology. The iPSC line showed normal karyotype, expressed pluripotency markers and differentiated into three germ layers in vivo. The cell line will serve as an available control in the research of pathological mechanisms of early-onset neurological diseases.

What problem does this paper attempt to address?

Generation of Induced Pluripotent Stem Cell Line (Zzui007-A) from a 52-Year-old Patient with a Novel CHCHD2 Gene Mutation in Parkinson's Disease.

Yanlin Wang,Zhilei Wang,Huifang Sun,Chengyuan Mao,Jing Yang,Yutao Liu,Han Liu,Shoutao Zhang,Jin Zhang,Yuming Xu,Changhe Shi

DOI: https://doi.org/10.1016/j.scr.2018.08.011

IF: 1.587

2018-01-01

Stem Cell Research

Abstract:CHCHD2 mutation has been reported as a potential cause of a rare form of familial Parkinson's disease. Recently, a novel CHCHD2 mutation was identified in a family with Parkinson's disease. The dermal fibroblasts of the patient were obtained and successfully transformed into induced pluripotent stem cells(iPSCs), employing episomal plasmids expressing OCT3/4, SOX2, KLF4, LIN28, and L-MYC. Our model may offer a good platform for further research on the pathomechanism, drug testing, and gene therapy of this disease.
Establishment of an Induced Pluripotent Stem Cell Line (Zjulli004-A) from a Hypertrophic Cardiomyopathy Patient Carrying MYBPC3/c.3764C>A Mutation

Yaxun Sun,Jingjun Zhou,Hongkun Wang,Hao Wang,Xianzhen Chen,Tingyu Gong,Ping Liang,Chenyang Jiang

DOI: https://doi.org/10.1016/j.scr.2022.102898

IF: 1.587

2022-01-01

Stem Cell Research

Abstract:Hypertrophic cardiomyopathy (HCM) is an inherited cardiovascular disease characterized by left ventricular hypertrophy and a high risk of sudden death. In this study, a skin biopsy was obtained from a HCM patient harboring a heterozygous missense mutation (c.3764C>A; p.A1225D) in the myosin binding protein C3 (MYBPC3) gene. The isolated fibroblasts were reprogrammed using non-integrated Sendai viral method to establish the patient-specific induced pluripotent stem cell (iPSC) line. The established iPSC line displayed normal morphology and karyotype, expressed pluripotency markers, and can differentiate into three germ layers in vivo.
Establishment of Induced Pluripotent Stem Cell Line (Zzui009-A) from an Alzheimer's Disease Patient Carrying a PSEN1 Gene Mutation

Yanlin Wang,Na Jing,Linlin Su,Changhe Shi,Pei Zhang,Zhilei Wang,Huifang Sun,Jing Yang,Yutao Liu,Xuejun Wen,Jin Zhang,Shoutao Zhang,Yuming Xu

DOI: https://doi.org/10.1016/j.scr.2017.12.005

IF: 1.587

2017-01-01

Stem Cell Research

Abstract:Skin fibroblasts were obtained from a 42-year-old Alzheimer's disease (AD) patient carrying mutations in the PSEN1 gene. An iPSC line was successfully established using the Sendai-virus (SeV) delivery system. The patient-specific iPSCs were free of genomically integrated reprogramming genes, had the specific mutation, expressed the expected pluripotency markers, and had the potential to differentiate into cells of all three germ layers. Our model might offer a robust platform for further study of the pathomechanism of this disease as well as drug testing and gene therapy studies.
Establishment of an Induced Pluripotent Stem Cell Line (Sdchi011-A) from a Healthy Chinese Female Donor

Shuyun Wang,Qian Zeng,Mengmeng Chen,Haiyan Zhang,Xin Lv

DOI: https://doi.org/10.1016/j.scr.2024.103588

IF: 1.587

2024-01-01

Stem Cell Research

Abstract:We generated an induced pluripotent stem cell (iPSC) line from peripheral blood mononuclear cells (PBMCs) of a healthy 40-year-old Chinese Han female, using non-integrated reprogramming technology. The established iPSC line, SDCHi011-A, expressed pluripotency marker and could differentiate into cells of three germ layers in vitro with normal karyotype. This cell line is a valuable resource as a control line for stem cell research of disease models and molecular pathogenesis.
Establishment of an Induced Pluripotent Stem Cell (ipsc) Line (Inndsui005-A) from a Healthy Female Chinese Han

Wenzhu Liu,Yingxin Wang,Yitong Yang,Yu Wang,Yao Tang,Yichang Jiao,Didi Shan,Zexin Zhan,Rui Zhang,Dongdong Wang,Xiaohan Sun,Ping Sun,Xiulian Sun,Chuanzhu Yan,Fuchen Liu

DOI: https://doi.org/10.1016/j.scr.2024.103386

IF: 1.587

2024-01-01

Stem Cell Research

Abstract:We obtained skin fibroblasts from a 34-year-old healthy woman and established a human induced pluripotent stem cell (hiPSC) line (INDSUi005-A) using a non-integrated reprogramming approach. The obtained cells have typical characteristics of embryonic stem cells, can express specific pluripotency markers and have the ability to differentiate into three germ layers in vitro. This iPSC cell line can be used as an in vitro model for studying disease mechanisms and developing novel therapies.
Establishment of Induced Pluripotent Stem Cell Line (Zzui010-A) from an Alzheimer's Disease Patient Carrying an APP Gene Mutation.

Zhilei Wang,Pei Zhang,Yanlin Wang,Changhe Shi,Na Jing,Huifang Sun,Jing Yang,Yutao Liu,Xuejun Wen,Jin Zhang,Shoutao Zhang,Yuming Xu

DOI: https://doi.org/10.1016/j.scr.2017.10.025

IF: 1.587

2017-01-01

Stem Cell Research

Abstract:Alzheimer's disease (AD) is one of the most common neurodegenerative disorders. Previous studies have identified mutations in several genes, such as amyloid precursor protein (APP), presenilin-1 (PSEN1), and presenilin-2 (PSEN2), in patients with early-onset (<65years) familial AD. Recently, a patient with an APP gene mutation was identified; the dermal fibroblasts of the patient were obtained and a line of induced pluripotent stem cells (iPSCs) was successfully generated using the Sendai-virus (SeV) delivery system. The iPSC line will be useful for further study of the pathomechanism and drug screening for AD.
Generation of a Human Induced Pluripotent Stem Cell Line from a 65-Year Old Healthy Female Donor with Chinese Han Genetic Background

Ying Wang,Jing Zhang,Yue Zhang,Danyi Huang,Jian Zhao,Gang Li,Ying Lei

DOI: https://doi.org/10.1016/j.scr.2017.08.008

IF: 1.587

2017-01-01

Stem Cell Research

Abstract:Peripheral blood mononuclear cells (PBMC) were collected from a 65-year old healthy woman with Chinese Han genetic background. The PBMCs were reprogrammed with the human OKSM transcription factors using the non-integrating episomal vector system. The transgene-free iPSC showed pluripotency verified by immunocytochemistry for pluripotency markers and differentiated spontaneously toward the 3 germ layers in vitro. Furthermore, the iPSC line showed normal karyotype. The iPSC line can be used as control in disease mechanism studies.
Establishment of an Induced Pluripotent Stem Cell Line (Csui003-A) from Fibroblasts of a Healthy Elderly Individual

Hongjun Zhao,Lijing Wang,Junjiao Wu,Jie Ren,Qiong Chen,Hui Luo,Xiaoxia Zuo,Yu Tang

DOI: https://doi.org/10.1016/j.scr.2021.102326

IF: 1.587

2021-01-01

Stem Cell Research

Abstract:Skin fibroblasts derived from a 71-year-old healthy woman were reprogrammed into induced pluripotent stem cells (iPSCs) by the transduction of retroviruses expressing OCT4, SOX2, KLF4 and c-MYC, respectively. The generated iPSCs maintained a normal karyotype and expressed various pluripotency markers. Moreover, they could be induced to form embryoid bodies in vitro and teratomas in vivo, indicating the full capacity of differentiating into three germ layers. This iPSC line could be differentiated into multiple cell subtypes for cellular modeling and drug discovery.
Establishment of an Induced Pluripotent Stem Cell (ipsc) Line (Inndsui001-A) from a Healthy Female Chinese Han.

Dongdong Wang,Rui Zhang,Yu Wang,Ping Sun,Xinbo Ji,Xiaohan Sun,Jingwen Xu,Dandan Zhao,Chuanzhu Yan,Fuchen Liu

DOI: https://doi.org/10.1016/j.scr.2022.102819

IF: 1.587

2022-01-01

Stem Cell Research

Abstract:We have established the human induced pluripotent stem cell (hiPSC) line (INNDSUi001-A) from skin fibroblasts of a healthy 24-year-old female individual by using non-integrating reprogramming method. The resulted cells had typical features of embryonic stem cell as indicated by expression of specific pluripotency markers and had the capability of in vitro differentiation into the three germ layers. This iPSC line can be used as a healthy control for disease study.
Establishment of induced pluripotent stem cell line SDPHi003-A from a healthy male donor

Yue Xi,Haiyan Zhang,Xiaomeng Yang,Dan Ai,Yi Liu,Wei Song

DOI: https://doi.org/10.1016/j.scr.2023.103160

Abstract:Peripheral blood mononuclear cells (PBMCs) were derived from a 67-year-old Chinese male. We used non-integrating episomal vectors containing OCT4, SOX2, KLF4 and c-MYC to reprogram PBMCs into induced pluripotent stem cell (iPSCs). This iPSC line, SDPHi003-A, have a normal karyotype, expressed pluripotent markers and have the potential for trilineage differentiation. This iPSC line can be used as a control for disease modeling studies and contribute to the research exploring disease pathogenesis.
An Induced Pluripotent Stem Cell Line (Csui004-A) from Skin Fibroblasts of a Healthy Individual

Lijing Wang,Hongjun Zhao,Junjiao Wu,Jie Ren,Hui Luo,Xiaoxia Zuo,Qiong Chen,Yu Tang

DOI: https://doi.org/10.1016/j.scr.2021.102336

IF: 1.587

2021-01-01

Stem Cell Research

Abstract:We established an induced pluripotent stem cell (iPSC) reprogrammed from dermal fibroblasts of a 53-year-old healthy man. Retroviruses expressing Yamanaka factors (OCT4, SOX2, KLF4 and c-MYC) were employed to initiate the reprogramming and were silenced in iPSCs. The generated iPSCs were pluripotent as determined by immunostaining and expression of pluripotency markers. They were further induced as embryoid bodies in vitro and teratomas in vivo, reminiscent of their full capacity of differentiating into three germ layers. They are with a normal karyotype and genetically identical to donor fibroblasts. This iPSC line provides excellent cell sources for studying and modeling human-specific physiology.
Generation of a Human-Derived Induced Pluripotent Stem Cell Line (Siaisi012-A) from an 82-Year-old Healthy Chinese Han Male.

Jinghui Guo,Fang,Qiuting Dai,Wenxin Zhang,Weihao Di,Jiaan Hu,Jian Zhao,Jiumei Cao,Ying Wang

DOI: https://doi.org/10.1016/j.scr.2021.102186

IF: 1.587

2021-01-01

Stem Cell Research

Abstract:As the global median population age increases, neurological diseases associated with aging pose significant challenges to human health. Appropriate modeling systems can be useful tools to better understand the mechanism of age-related neuronal degeneration diseases. Here, we successfully generated an iPSC-derived modeling system of an 82-year-old healthy man, this newly established line showed that all pluripotent markers were expressed, and the differentiation potential was confirmed by trilineage differentiation. STR profiling proved the cell line identity, and G-binding showed the normal karyotype.
Induced Pluripotent Stem Cell Line (Zzuneui011-A) Derived from Peripheral Blood Mononuclear Cells (pbmcs) of a Healthy 27-Year-old Female Individual.

Wanrong Fu,Mengyu Wang,Yangyang Liu,Mengduan Liu,Lu Wang,Liang Hu,Xiaoyan Zhao,Zhongren Ding,Xiaowei Li,Jianzeng Dong

DOI: https://doi.org/10.1016/j.scr.2020.102139

IF: 1.587

2020-01-01

Stem Cell Research

Abstract:In this study, we report a human induced pluripotent stem cell (iPSC) line from a healthy 27-year-old female individual using non-integrative Sendai viral reprogramming technology. The cell line expresses stemness markers, exhibits a normal female karyotype, and can differentiate into three germ layers in vivo. This iPSC line from a healthy individual provides a control group for studying disease mechanisms, drug screening, and toxicity testing.
Generation of Induced Pluripotent Stem Cell Line (Zzui0013-A) from a 65-Year-old Patient with a Novel MEOX2 Gene Mutation in Alzheimer's Disease.

Yanlin Wang,Huifang Sun,Jing Yang,Changhe Shi,Yutao Liu,Yuming Xu,Jin Zhang

DOI: https://doi.org/10.1016/j.scr.2018.101366

IF: 1.587

2018-01-01

Stem Cell Research

Abstract:MEOX2 mutation has been reported as a potential cause of familial Alzheimer's disease. Recently, a novel MEOX2 mutation was identified in a family with Alzheimer's disease. The dermal fibroblasts of the patient were obtained and successfully transformed into induced pluripotent stem cells (iPSCs), employing episomal plasmids expressing OCT3/4, SOX2, KLF4, LIN28, and L-MYC. Our model may offer a good platform for further research on the pathomechanism, drug testing, and gene therapy of this disease.
Construction of induced pluripotent stem cell line (CSBZZUi002-A) from the fibroblast cells of a healthy female

Yue Wu,Xiao-Yan Meng,Hui-Fang Sun,Ying-Jie Zhang,Xiao-Hui Liu,Dian-Dian Wang,Dan-Hua Liu,Sen-Miao Li,Jia-Kang Li,Wen-Xiu Li,Shu-Ang Li,Pei-Pei Liu,Jian-Sheng Kang

DOI: https://doi.org/10.1016/j.scr.2024.103593

IF: 1.587

2024-10-21

Stem Cell Research

Abstract:We recruited a healthy 44-year-old female and obtained her skin fibroblasts. Subsequently, the induced pluripotent stem cell line was successfully established using non-integrated reprogramming technology. The cell line had a normal karyotype and has been confirmed to have good pluripotency through the detection of pluripotency markers and detection of teratoma formation. This cell line can serve as an effective control for studying the cellular pathological mechanisms of other specific mutations.

cell biology,biotechnology & applied microbiology,cell & tissue engineering
An achievement has been made in establishing an induced pluripotent stem cell line (SDPHi005-A) from a healthy Chinese male donor

Jing Shao,Yan Jin,Chunhong Shao,Xiaoqiao Zhang,Guang Yang

DOI: https://doi.org/10.1016/j.scr.2024.103393

IF: 1.587

2024-03-18

Stem Cell Research

Abstract:Successfully transforming isolated peripheral blood mononuclear cells (PBMCs) from a healthy male into induced pluripotent stem cells (iPSCs) was achieved using non-integrating episomal vectors containing OCT4, SOX2, c-MYC, KLF4, and BCL-XL. The iPSCs exhibited a normal karyotype, expressed pluripotency markers, and demonstrated the ability to differentiate into three germ layers in vitro. This iPSC line may be employed for subsequent research purposes.

cell biology,biotechnology & applied microbiology,cell & tissue engineering
Generation of a control induced pluripotent stem cell line (SDUCHi001-A) from a healthy male donor

Chunmiao Li,Fengjuan Zhang,Xiaoyi Wang,Mengmeng Chen

DOI: https://doi.org/10.1016/j.scr.2024.103433

IF: 1.587

2024-05-03

Stem Cell Research

Abstract:An induced pluripotent stem cell (iPSC) line (SDUCHi001-A) was established using peripheral blood mononuclear cells (PBMCs) from a healthy 6 years old boy. Reprogramming of the PBMCs was achieved through non-integrating delivery of OCT4, SOX2, KFL4, BCL-XL, and c-MYC. The iPSC line expressed pluripotency markers, had a normal karyotype and trilineage differentiation potential.

cell biology,biotechnology & applied microbiology,cell & tissue engineering
Generation of a Human Induced Pluripotent Stem Cell Line from a Female Patient Carrying LZTR1 Gene Mutation

Jinghua Ruan,Mengqing Wu,Jiakai Xiang,Xianrui Hui,Lijun Yang,Ru Lin,Weize Xu,Qiang Shu

DOI: https://doi.org/10.1016/j.scr.2024.103616

IF: 1.587

2024-01-01

Stem Cell Research

Abstract:The leucine zipper-like transcriptional regulator 1 (LZTR1) gene has been reported to be associated with many kinds of human diseases, including cardiac disease, Noonan syndrome, and schwannomatosis. In this study, peripheral blood mononuclear cells (PBMCs) derived from patient diagnosed with dilated cardiomyopathy (DCM) was successfully reprogrammed into the human induced pluripotent stem cells (iPSCs) line, harboring a distinct heterozygous mutation in the LZTR1 gene. The established patient-derived iPSCs expressed endogenous pluripotent markers, demonstrated the potential to differentiate into three germ layers (endoderm, mesoderm, and ectoderm), and exhibited a normal karyotype.
Generation of a Human Control PBMC Derived Ips Cell Line TUSMi001-A from a Healthy Male Donor of Han Chinese Genetic Background

Ying Wang,Yue Zhang,Jing Zhang,Jing Lu,Chaowen Yang,Jian Zhao,Gang Li,Zhongmin Liu,Ying Lei

DOI: https://doi.org/10.1016/j.scr.2017.10.006

IF: 1.587

2017-01-01

Stem Cell Research

Abstract:A 59-year old healthy man of Han Chinese genetic background donated his peripheral blood mononuclear cells (PBMC). The non-integrating episomal vector system was used to reprogram his PBMCs with the human OSKM (Oct4, Sox2, Kl4 and c-Myc) transcription factors. The pluripotency of transgene-free iPSCs was confirmed by immunocytochemistry for pluripotency markers and by the ability of the iPSCs to differentiate spontaneously into 3 germ layers in vitro. In addition, the iPSC line displayed a normal karyotype. In the studies of disease mechanism, the iPSC line can be used as a control.
Generation of an induced pluripotent stem cell line (SHCDNi003-A) from a one-year-old Chinese Han infant with Allan-Herndon-Dudley syndrome.

Anqi Wang,Jiaming Xi,Fang Yuan,Yilin Wang,Simei Wang,Chunmei Wang,Chao Wang,Longlong Lin,Xiaona Luo,Quanmei Xu,Rongrong Yin,Hongyi Cheng,Yuanfeng Zhang,Xiaomin Sun,Jie Yang,Jingbin Yan,Fanyi Zeng,Yucai Chen

DOI: https://doi.org/10.1016/j.scr.2020.101872

IF: 1.587

2020-01-01

Stem Cell Research

Abstract:Allan-Herndon-Dudley syndrome (AHDS) is a rare, X-chromosome-linked inherited disorder that affects brain development and is caused by a mutation in SLC16A2. Herein, we generated an induced pluripotent stem cell (iPSC) line from the peripheral blood mononuclear cells of a one-year-old male infant with AHDS using Sendai-virus-mediated reprogramming. These iPSCs exhibited stable amplification, expressed pluripotent markers, and differentiated spontaneously into three germ layers in vitro. Additionally, this iPSC line was found to maintain a normal karyotype and retain the pathogenic mutation in SLC16A2, facilitating the study of disease mechanisms and development of new therapies of AHDS.

Construction of Induced Pluripotent Stem Cell Line (Zzui031-A) of a Healthy Young Chinese Han Male

Generation of Induced Pluripotent Stem Cell Line (Zzui007-A) from a 52-Year-old Patient with a Novel CHCHD2 Gene Mutation in Parkinson's Disease.

Establishment of an Induced Pluripotent Stem Cell Line (Zjulli004-A) from a Hypertrophic Cardiomyopathy Patient Carrying MYBPC3/c.3764C>A Mutation

Establishment of Induced Pluripotent Stem Cell Line (Zzui009-A) from an Alzheimer's Disease Patient Carrying a PSEN1 Gene Mutation

Establishment of an Induced Pluripotent Stem Cell Line (Sdchi011-A) from a Healthy Chinese Female Donor

Establishment of an Induced Pluripotent Stem Cell (ipsc) Line (Inndsui005-A) from a Healthy Female Chinese Han

Establishment of Induced Pluripotent Stem Cell Line (Zzui010-A) from an Alzheimer's Disease Patient Carrying an APP Gene Mutation.

Generation of a Human Induced Pluripotent Stem Cell Line from a 65-Year Old Healthy Female Donor with Chinese Han Genetic Background

Establishment of an Induced Pluripotent Stem Cell Line (Csui003-A) from Fibroblasts of a Healthy Elderly Individual

Establishment of an Induced Pluripotent Stem Cell (ipsc) Line (Inndsui001-A) from a Healthy Female Chinese Han.

Establishment of induced pluripotent stem cell line SDPHi003-A from a healthy male donor

An Induced Pluripotent Stem Cell Line (Csui004-A) from Skin Fibroblasts of a Healthy Individual

Generation of a Human-Derived Induced Pluripotent Stem Cell Line (Siaisi012-A) from an 82-Year-old Healthy Chinese Han Male.

Induced Pluripotent Stem Cell Line (Zzuneui011-A) Derived from Peripheral Blood Mononuclear Cells (pbmcs) of a Healthy 27-Year-old Female Individual.

Generation of Induced Pluripotent Stem Cell Line (Zzui0013-A) from a 65-Year-old Patient with a Novel MEOX2 Gene Mutation in Alzheimer's Disease.

Construction of induced pluripotent stem cell line (CSBZZUi002-A) from the fibroblast cells of a healthy female

An achievement has been made in establishing an induced pluripotent stem cell line (SDPHi005-A) from a healthy Chinese male donor

Generation of a control induced pluripotent stem cell line (SDUCHi001-A) from a healthy male donor

Generation of a Human Induced Pluripotent Stem Cell Line from a Female Patient Carrying LZTR1 Gene Mutation

Generation of a Human Control PBMC Derived Ips Cell Line TUSMi001-A from a Healthy Male Donor of Han Chinese Genetic Background

Generation of an induced pluripotent stem cell line (SHCDNi003-A) from a one-year-old Chinese Han infant with Allan-Herndon-Dudley syndrome.